Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

by Ahmed Abdelhak, Martin S. Weber, Martin S. Weber, Hayrettin Tumani, Hayrettin Tumani
Published 2017-05-01

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

by André Huss, Markus Otto, Makbule Senel, Albert C. Ludolph, Ahmed Abdelhak, Ahmed Abdelhak, Hayrettin Tumani, Hayrettin Tumani
Published 2020-07-01

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing

by Franziska Bachhuber, André Huss, Makbule Senel, Hayrettin Tumani
Published 2021-05-01

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

by Hela-Felicitas Petereit, Hayrettin Tumani, Uwe K. Zettl
Published 2021-06-01

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort

by Makbule Senel, Fatemeh Mojib-Yezdani, Ulrike Braisch, Franziska Bachhuber, Jan Lewerenz, Albert C. Ludolph, Markus Otto, Hayrettin Tumani, Hayrettin Tumani
Published 2019-03-01

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases

by Johannes Dorst, Frank Fillies, Jens Dreyhaupt, Makbule Senel, Hayrettin Tumani
Published 2020-09-01

Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report

by Daniel Rapp, Mirjam Keßler, Elmar Pinkhardt, Markus Otto, Hayrettin Tumani, Makbule Senel
Published 2020-06-01

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies

by Alexander J. Davies, Janev Fehmi, Makbule Senel, Hayrettin Tumani, Johannes Dorst, Simon Rinaldi
Published 2020-06-01

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

by Daniela Rau, Michael Lang, Andreas Harth, Markus Naumann, Frank Weber, Hayrettin Tumani, Antonios Bayas
Published 2015-06-01

Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.

by Makbule Senel, Hayrettin Tumani, Florian Lauda, Stefan Presslauer, Rehaneh Mojib-Yezdani, Markus Otto, Johannes Brettschneider
Published 2014-01-01

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

by Ahmed Abdelhak, Andreas Junker, Johannes Brettschneider, Jan Kassubek, Albert C. Ludolph, Markus Otto, Hayrettin Tumani
Published 2015-07-01

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.

by Ahmed Abdelhak, Tilman Hottenrott, Christoph Mayer, Gudrun Hintereder, Uwe K Zettl, Oliver Stich, Hayrettin Tumani
Published 2017-01-01

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

by Viviana A. Carcamo Yañez, Jens C. Göpfert, Markus Otto, Hayrettin Tumani, Andreas Peter, Thomas O. Joos
Published 2017-11-01

Cerebrospinal fluid biomarkers in multiple sclerosis

by Hayrettin Tumani, Hans-Peter Hartung, Bernhard Hemmer, Charlotte Teunissen, Florian Deisenhammer, Gavin Giovannoni, Uwe K. Zettl
Published 2009-08-01

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.

by Petra Steinacker, Lubin Fang, Jens Kuhle, Axel Petzold, Hayrettin Tumani, Albert C Ludolph, Markus Otto, Johannes Brettschneider
Published 2011-01-01

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies

by André Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto, Hayrettin Tumani
Published 2020-08-01

Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections

by Makbule Senel, Daniel Rapp, Benjamin Mayer, Sarah Jesse, Sigurd D. Süssmuth, Markus Otto, Jan Lewerenz, Hayrettin Tumani
Published 2020-09-01

IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.

by Johannes Brettschneider, Hayrettin Tumani, Ulrike Kiechle, Rainer Muche, Gayle Richards, Vera Lehmensiek, Albert C Ludolph, Markus Otto
Published 2009-11-01

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

by Ahmed Abdelhak, Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas-Rodríguez, Estrella Morenas-Rodríguez, Marc Suárez-Calvet, Uwe K. Zettl, Christian Haass, Christian Haass, Christian Haass, Sven G. Meuth, Sebastian Rauer, Markus Otto, Hayrettin Tumani, Hayrettin Tumani, André Huss
Published 2019-03-01

A proteomic approach for the diagnosis of bacterial meningitis.

by Sarah Jesse, Petra Steinacker, Stefan Lehnert, Martin Sdzuj, Lukas Cepek, Hayrettin Tumani, Olaf Jahn, Holger Schmidt, Markus Otto
Published 2010-01-01